SPRIAFIL

This brand name is authorized in Mexico

Active ingredients

The drug SPRIAFIL contains one active pharmaceutical ingredient (API):

1 Posaconazole
UNII 6TK1G07BHZ - POSACONAZOLE

Posaconazole inhibits the enzyme lanosterol 14ฮฑ-demethylase (CYP51), which catalyses an essential step in ergosterol biosynthesis.

Read about Posaconazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J02AC04 Posaconazole J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AC Triazole and tetrazole derivatives
Discover more medicines within J02AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: MX Comisiรณn Federal para la Protecciรณn contra Riesgos Sanitarios Identifier(s): 018M2017, 369M2014

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈